375 related articles for article (PubMed ID: 29107295)
1. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
[TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
[TBL] [Abstract][Full Text] [Related]
3. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.
Gastaldelli A; Iaconelli A; Gaggini M; Magnone MC; Veneziani A; Rubino F; Mingrone G
Diabetes Care; 2016 Nov; 39(11):1925-1931. PubMed ID: 27573937
[TBL] [Abstract][Full Text] [Related]
4. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
[TBL] [Abstract][Full Text] [Related]
5. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
[TBL] [Abstract][Full Text] [Related]
6. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
8. Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?
Crujeiras AB; Gomez-Arbelaez D; Zulet MA; Carreira MC; Sajoux I; de Luis D; Castro AI; Baltar J; Baamonde I; Sueiro A; Macias-Gonzalez M; Bellido D; Tinahones FJ; Martinez JA; Casanueva FF
Int J Obes (Lond); 2017 Oct; 41(10):1570-1578. PubMed ID: 28588304
[TBL] [Abstract][Full Text] [Related]
9. Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects.
Lips MA; de Groot GH; Berends FJ; Wiezer R; van Wagensveld BA; Swank DJ; Luijten A; van Dijk KW; Pijl H; Jansen PL; Schaap FG
Clin Endocrinol (Oxf); 2014 Dec; 81(6):862-70. PubMed ID: 24841294
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
11. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery.
de Weijer BA; Aarts E; Janssen IM; Berends FJ; van de Laar A; Kaasjager K; Ackermans MT; Fliers E; Serlie MJ
Obesity (Silver Spring); 2013 Jun; 21(6):1143-7. PubMed ID: 23913729
[TBL] [Abstract][Full Text] [Related]
12. Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypass.
Vienberg SG; Jacobsen SH; Worm D; Hvolris LE; Naver L; Almdal T; Hansen DL; Wulff BS; Clausen TR; Madsbad S; Holst JJ; Andersen B
Clin Endocrinol (Oxf); 2017 Jan; 86(1):156-159. PubMed ID: 27649688
[TBL] [Abstract][Full Text] [Related]
13. Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls.
Vienberg SG; Brøns C; Nilsson E; Astrup A; Vaag A; Andersen B
Eur J Endocrinol; 2012 Jul; 167(1):49-57. PubMed ID: 22529197
[TBL] [Abstract][Full Text] [Related]
14. Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans.
Tamboli RA; Antoun J; Sidani RM; Clements A; Harmata EE; Marks-Shulman P; Gaylinn BD; Williams B; Clements RH; Albaugh VL; Abumrad NN
Diabetes Obes Metab; 2017 Sep; 19(9):1267-1275. PubMed ID: 28345790
[TBL] [Abstract][Full Text] [Related]
15. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.
Woelnerhanssen B; Peterli R; Steinert RE; Peters T; Borbély Y; Beglinger C
Surg Obes Relat Dis; 2011; 7(5):561-8. PubMed ID: 21429816
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
17. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
[TBL] [Abstract][Full Text] [Related]
19. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
20. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
